Atrial fibrillation screening in 75- and 76-year-olds may significantly reduce the risk of stroke, severe bleeding, and death. The study, published in The Lancet, found that at least 2,300 cases of stroke or death could be avoided per year with national screening.
The ESC guidelines on cardiac pacing and CRT introduce novel approaches to pacing the conduction system, including physiological pacing and His bundle left bundle pacing. The guidelines also provide recommendations for reducing complications and improving patient outcomes, such as remote monitoring and patient-centred care.
A new strategy using a pill containing four medicines has been shown to be more effective in getting blood pressure under control compared to traditional monotherapy, with 80% of participants achieving blood pressure control within 12 weeks.
International genetic research projects struggle with GDPR interpretation due to ambiguous rules on personal data, consent, and data transfer outside the EU/EEA. Measures to reduce these challenges are proposed, including a more genetics-sensitive approach with regulators.
A study of 20,304 kidney transplants found that black recipients and patients receiving kidneys from Asian donors had a higher risk of graft failure within seven years. The study suggests that improved access to organ donation among ethnic minority groups can improve long-term outcomes for all recipients.
Researchers found that strokes affecting specific brain regions can cause distinct reading problems, which could help clinicians develop personalized therapies. The study's findings have implications for understanding post-stroke language and reading deficits.
Research identifies genetic variants associated with adherence to medication, suggesting a link between individual behavior and biological factors. The study found positive correlations between adherence and traits controlled by multiple genes, such as educational achievement and body mass index.
A combination therapy of aspirin, statins, and at least two blood pressure medications cuts the risk of fatal cardiovascular disease by over half. The treatment strategy, known as a polypill, is consistent in benefits across different blood pressure levels, cholesterol levels, and diabetes status.